2017
DOI: 10.1371/journal.pone.0189500
|View full text |Cite
|
Sign up to set email alerts
|

Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment

Abstract: ObjectiveThe protein hormone adiponectin promotes metabolic and psychological health. The aim of the study was to track changes in adiponectin levels in response to weight gain and to assess associations between adiponectin and psychological aspects in patients with anorexia nervosa (AN).MethodsTo investigate if adiponectin levels depend on AN severity, data were assessed from 11 inpatients with a very low body mass index (BMI) and a high chronicity (high severity group; HSS), and nine with less severe symptom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
3
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 48 publications
1
3
1
Order By: Relevance
“…In other words, ABA mice have relatively low levels of blood adiponectin, which diminishes the appetite-enhancing effects of adiponectin despite being hungry. In support of our speculation, Buckert et al [58] investigated temporal changes of the plasma adiponectin levels of AN patients with and without severe symptoms in a clinical intervention study, only observing hyperadiponectinemia in subjects with mild to moderate severity (BMI 16 or over) at the beginning. However, the plasma adiponectin level of severe AN patients (BMI under 16) increased in increments of BMI up to 16 during the treatment phase, then decreased with further weight gain.…”
Section: Plos Onesupporting
confidence: 64%
“…In other words, ABA mice have relatively low levels of blood adiponectin, which diminishes the appetite-enhancing effects of adiponectin despite being hungry. In support of our speculation, Buckert et al [58] investigated temporal changes of the plasma adiponectin levels of AN patients with and without severe symptoms in a clinical intervention study, only observing hyperadiponectinemia in subjects with mild to moderate severity (BMI 16 or over) at the beginning. However, the plasma adiponectin level of severe AN patients (BMI under 16) increased in increments of BMI up to 16 during the treatment phase, then decreased with further weight gain.…”
Section: Plos Onesupporting
confidence: 64%
“…Low levels of adiponectin were found in several psychiatric conditions, including severe depression (Carvalho et al 2014;Diniz et al 2012) and anxiety disorders (Unsal et al 2012). In addition, higher levels of adiponectin were significantly related to lower self-ratings of depression and anxiety but stress in patients with anorexia nervosa during inpatient treatment (Buckert et al 2017). In this cross-sectional study in a young Nigerian population, we did not see any significant association between ADIPOQ rs1501299 and psychological factors.…”
Section: Discussioncontrasting
confidence: 51%
“…gain in AN are a few, and the results are conflicting (Bosy-Westphal et al, 2005;Buckert et al, 2017;Modan-Moses et al, 2007). We need additional studies that explore the effects of re-feeding on adiponectin levels and other systems, such as bone and glucose metabolism and pro-inflammatory systems in AN.…”
Section: Discussionmentioning
confidence: 99%
“…Monitoring the changes in adiponectin levels during weight gain in patients with AN could provide valuable information to understand the underpinning biological mechanisms. Yet, the studies monitoring the changes in adiponectin levels before and after re‐feeding and weight gain in AN are a few, and the results are conflicting (Bosy‐Westphal et al, 2005; Buckert et al, 2017; Modan‐Moses et al, 2007). We need additional studies that explore the effects of re‐feeding on adiponectin levels and other systems, such as bone and glucose metabolism and pro‐inflammatory systems in AN.…”
Section: Discussionmentioning
confidence: 99%